Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder

NCT01119430 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped interim analysis suggested no differences with whole sample

Conditions

Major Depression

Interventions

DRUG: DU125530
DRUG: Placebo

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau